These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18987766)

  • 1. First Canadian experience with high-risk percutaneous coronary intervention with assistance of a percutaneously deployed left ventricular assist device.
    Eichhöfer J; Osten M; Horlick E; Dzavík V
    Can J Cardiol; 2008 Nov; 24(11):e82-5. PubMed ID: 18987766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impella ventricular assist device: use in patients at high risk for coronary interventions: successful multivessel percutaneous coronary intervention in a 62-year-old high-risk patient.
    Marella PC; Lassetter JE; Heuser RR
    Cardiovasc Revasc Med; 2011; 12(1):69.e9-12. PubMed ID: 21036108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-risk left main coronary stenting supported by percutaneous Impella Recover LP 2.5 assist device].
    Cohen R; Foucher R; Sfaxi A; Hakim M; Domniez T; Elhadad S
    Ann Cardiol Angeiol (Paris); 2010 Feb; 59(1):48-51. PubMed ID: 18789429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk left main coronary stenting supported by percutaneous Impella Recover LP 2.5 assist device.
    Cohen R; Domniez T; Elhadad S
    J Invasive Cardiol; 2007 Oct; 19(10):E294-6. PubMed ID: 17906353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Ventricular Assist Devices: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(2):1-97. PubMed ID: 28232854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanical cardiac-assist devices in ST segment elevation myocardial infarction].
    Spaulding C
    Ann Cardiol Angeiol (Paris); 2015 Dec; 64(6):513-6. PubMed ID: 26482626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an Impella 2.5 percutaneous left ventricular assist device.
    Harmon L; Boccalandro F
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1129-34. PubMed ID: 21805597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left main coronary artery transradial rescue percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock with Impella ventricular mechanical support.
    Dahdouh Z; Roule V; Lognoné T; Sabatier R; Grollier G
    Cardiovasc Revasc Med; 2012; 13(2):142.e1-4. PubMed ID: 22019211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience with the Impella Recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty.
    Thomopoulou S; Manginas A; Cokkinos DV
    Hellenic J Cardiol; 2008; 49(6):382-7. PubMed ID: 19110924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
    Al-Husami W; Yturralde F; Mohanty G; Pastore C; Lotun K; Venesy D; Waxman S; Pyne C; Gossman D; Nesto R; Piemonte T
    J Invasive Cardiol; 2008 Jun; 20(6):319-22. PubMed ID: 18523330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left ventricular assist device, TandemHeart, for high-risk percutaneous coronary revascularization. A single centre experience.
    Giombolini C; Notaristefano S; Santucci S; Fortunati F; Savino K; Sindaco FD; Ragni T; Allegri M; Ambrosio G
    Acute Card Care; 2006; 8(1):35-40. PubMed ID: 16720426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
    Mahmud E; Dominguez A; Bahadorani J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):565-570. PubMed ID: 27189238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
    Aragon J; Lee MS; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):346-52. PubMed ID: 15945107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous left ventricular support devices.
    Lee MS; Makkar RR
    Cardiol Clin; 2006 May; 24(2):265-75, vii. PubMed ID: 16781943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.